Plaque removal plus balloon: better for leg artery blockages?
NCT ID NCT07406308
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two ways to treat chronic blockages in the leg arteries: using a drug-coated balloon alone versus using the balloon along with a plaque-removal procedure (like laser or atherectomy). About 408 people with blocked leg arteries will be enrolled. The main goal is to see which approach keeps the artery open longer after one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
paclitaxel-coated balloon
What this could lead to
If successful, this could show that adding plaque removal to balloon treatment improves long-term artery openness for people with leg artery blockages.
What could go wrong
This is a very early (Phase 1) trial, so results are uncertain. The study hasn't started recruiting yet, and the approach may not prove better than the standard balloon alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEMOROPOPLITEAL ARTERY OCCLUSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking Union Medical College Hospital
Beijing, 100730, China
Contact Phone: •••-•••-•••• Email: •••••@•••••